VIVEK POUDEL: Open Payments
NPI 1407581283 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,374 in 227 payments from 17 companies in 2025. Trend: 2023 $2,618 · 2024 $3,049 · 2025 $4,374
Food & beverage: $4,374
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 40 | $930 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 34 | $566 |
| E.R. Squibb & Sons, L.L.C. | 28 | $507 |
| Otsuka America Pharmaceutical, Inc. | 26 | $500 |
| Corium, LLC | 16 | $356 |
| Takeda Pharmaceuticals U.S.A., Inc. | 19 | $346 |
| Vanda Pharmaceuticals Inc. | 13 | $255 |
| Lundbeck LLC | 13 | $238 |
| Axsome Therapeutics, Inc. | 11 | $226 |
| Bausch Health US, LLC | 11 | $174 |
Products named: VRAYLAR, REXULTI, CAPLYTA, COBENFY, Azstarys, TRINTELLIX, FANAPT, Auvelity.
Industry payments across TX — which companies pay providers there.
